Teachers Advisors LLC grew its position in shares of PerkinElmer, Inc. (NYSE:PKI) by 2.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 355,584 shares of the medical research company’s stock after purchasing an additional 8,904 shares during the quarter. Teachers Advisors LLC owned approximately 0.32% of PerkinElmer worth $24,229,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Envestnet Asset Management Inc. increased its position in shares of PerkinElmer by 28.1% during the 1st quarter. Envestnet Asset Management Inc. now owns 1,979 shares of the medical research company’s stock valued at $115,000 after purchasing an additional 434 shares during the last quarter. Twin Tree Management LP bought a new position in shares of PerkinElmer during the 1st quarter valued at about $122,000. Ameritas Investment Partners Inc. bought a new position in shares of PerkinElmer during the 1st quarter valued at about $152,000. LS Investment Advisors LLC increased its position in shares of PerkinElmer by 36.9% during the 1st quarter. LS Investment Advisors LLC now owns 2,817 shares of the medical research company’s stock valued at $164,000 after purchasing an additional 759 shares during the last quarter. Finally, Harvest Management LLC bought a new position in shares of PerkinElmer during the 1st quarter valued at about $201,000. Hedge funds and other institutional investors own 91.47% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of international copyright laws. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/23/teachers-advisors-llc-purchases-8904-shares-of-perkinelmer-inc-pki.html.

Shares of PerkinElmer, Inc. (NYSE PKI) opened at 68.17 on Friday. The company’s 50-day moving average price is $66.08 and its 200 day moving average price is $63.21. PerkinElmer, Inc. has a one year low of $45.35 and a one year high of $70.16. The stock has a market capitalization of $7.51 billion, a PE ratio of 20.56 and a beta of 0.74.

PerkinElmer (NYSE:PKI) last issued its quarterly earnings data on Thursday, August 3rd. The medical research company reported $0.67 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.67. PerkinElmer had a return on equity of 13.44% and a net margin of 16.80%. The company had revenue of $547.00 million for the quarter, compared to analysts’ expectations of $554.14 million. During the same period in the previous year, the firm posted $0.67 earnings per share. The firm’s revenue for the quarter was up 2.0% on a year-over-year basis. Analysts anticipate that PerkinElmer, Inc. will post $2.89 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, October 20th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, October 19th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.41%. PerkinElmer’s dividend payout ratio is 8.46%.

Several equities analysts have recently commented on PKI shares. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $78.00 price objective on the stock in a research report on Wednesday, July 19th. Morgan Stanley reiterated an “overweight” rating and set a $79.00 price objective (up from $73.00) on shares of PerkinElmer in a research report on Monday, July 10th. Piper Jaffray Companies increased their price objective on PerkinElmer to $80.00 and gave the company an “overweight” rating in a research report on Tuesday, July 25th. Cantor Fitzgerald set a $65.00 price objective on PerkinElmer and gave the company a “hold” rating in a research report on Monday, June 19th. Finally, Evercore ISI reiterated an “in-line” rating and set a $68.00 price objective (up from $62.50) on shares of PerkinElmer in a research report on Thursday, June 22nd. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company’s stock. PerkinElmer has a consensus rating of “Hold” and an average price target of $67.50.

About PerkinElmer

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.